| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $43,831,447 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI175439 | Anti-flavivirus B cell response analysis to aid vaccine design | 000 | 2 | NIH | 1/19/2024 | $694,219 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI168192 | Mechanisms coordinating the local and systemic resistance to pathogens | 000 | 2 | NIH | 10/24/2023 | $536,463 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI174952 | Decoding HIV-1 mediated Hematopathology | 000 | 2 | NIH | 1/25/2024 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS129502 | Role of reactive astrocytes in prion diseases | 000 | 2 | NIH | 11/9/2023 | $560,291 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI168603 | Age-dependent role of interferon lambda in protection against pertussis lethality in infants | 000 | 2 | NIH | 10/24/2023 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI174374 | Methylglyoxal-induced macrophage metabolic dysregulation in sepsis | 000 | 2 | NIH | 10/24/2023 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK133421 | Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis | 000 | 2 | NIH | 1/17/2024 | $485,056 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI172077 | Pretransplant comprehensive scores to predict long term graft outcomes | 000 | 2 | NIH | 2/5/2024 | $209,261 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH129310 | Behavioral and neural mechanisms mediating social motivation in a rat model for ASD | 000 | 2 | NIH | 10/18/2023 | $398,666 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA269995 | Nanotherapeutic enhancement of interstitial thermal therapy for glioblastoma | 000 | 2 | NIH | 11/16/2023 | $571,318 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 000 | 2 | NIH | 12/20/2023 | $503,935 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI172487 | Broadly neutralizing antibody combinations with single virions in HIV+ plasma | 000 | 2 | NIH | 12/5/2023 | $347,625 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI176774 | Impact of infection complexity on P. falciparum sexual commitment and gametocytemia | 000 | 2 | NIH | 3/6/2024 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R34AR082550 | A Planning Grant for a Multicenter Randomized Clinical Trial Comparing Hip Arthroplasty to Internal Fixation for Minimally Displaced Femoral Neck Fractures | 000 | 2 | NIH | 2/8/2024 | $99,004 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F31DA057817 | Sex Differences in Endocannabinoid Regulation of Behavioral Flexibility | 000 | 2 | NIH | 11/16/2023 | $40,834 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162940 | Computational Modeling of Device-Induced Platelet Activation and Receptor Shedding Relevant to Thrombosis and Bleeding in Device-Assisted Circulation | 000 | 2 | NIH | 11/14/2023 | $461,563 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA271540 | Tumor-barcoding coupled with high-throughput sequencing for quantitative radiogenomics of the abscopal response in NSCLC | 000 | 2 | NIH | 12/15/2023 | $468,472 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30AI174890 | Characterization of HIV-1 Genome Dimerization: A Strain Specific Dimerization Mechanism | 000 | 2 | NIH | 3/14/2024 | $52,694 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R33AT009990 | Prebiotic Treatment in People with Schizophrenia | 000 | 4 | NIH | 2/23/2024 | $30,943 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21MH129809 | Estrogen modulation of the lateral habenula and its ability to inhibit midbrain dopamine neurons | 000 | 2 | NIH | 1/4/2024 | $173,813 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25DE032530 | Maryland Program in Dental Research Experience (D-REX) | 000 | 2 | NIH | 12/14/2023 | $135,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI172827 | Multi-Omics Characterization of Plasmodium Vivax Hypnozoites | 000 | 2 | NIH | 11/13/2023 | $634,512 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HD108705 | Intersection of the mTOR/p70S6K1 signaling and the HIPPO-Yap tissue organizer in neurulation and diabetic embryopathy | 000 | 2 | NIH | 11/14/2023 | $586,642 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL167012 | A mechanistic understanding of treatment-related outcomes of sleep disordered breathing using functional near infrared spectroscopy | 000 | 2 | NIH | 2/16/2024 | $533,816 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG079854 | Methods to Test Biomarkers of Aging as Shared Determinants of Alzheimers Disease and Related Dementias and Physical Disability | 000 | 2 | NIH | 11/10/2023 | $682,648 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG3DA056039 | PTPRD phosphatase inhibitors for stimulant use disorders | 000 | 2 | NIH | 2/23/2024 | $155,345 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG077541 | The inflammatory mechanisms underlying olfactory dysfunction in prognosis of TBI progression to dementia | 000 | 3 | NIH | 3/12/2024 | $567,969 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R61AI154632 | Self-test HIV diagnostics utilizing structurally novel, shark-derived binding domains | 000 | 3 | NIH | 1/24/2024 | $323,005 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R61AI154632 | Self-test HIV diagnostics utilizing structurally novel, shark-derived binding domains | 000 | 3 | NIH | 1/24/2024 | $90,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG073136 | Age-related decline in endogenous pain modulation and its impact on osteoarthritis pain | 000 | 3 | NIH | 3/12/2024 | $458,677 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T32GM144951 | UMB IMSD | 000 | 3 | NIH | 1/23/2024 | $237,523 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM144147 | Photonics-based Fluorescence Imaging for Research, Diagnostics, and Pathology | 000 | 3 | NIH | 1/17/2024 | $347,625 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL162120 | Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis | 000 | 3 | NIH | 1/4/2024 | $578,478 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM140983 | Trauma and Shock-Induced Microvascular Dysregulation and Coagulopathy | 000 | 3 | NIH | 1/22/2024 | $553,733 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL165634 | Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function | 000 | 2 | NIH | 3/11/2024 | $18,758 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R37NS125632 | KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target | 000 | 3 | NIH | 12/12/2023 | $326,498 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS120930 | Molecular basis for adenosine A3 receptor agonists in the treatment of migraine | 000 | 3 | NIH | 11/28/2023 | $425,628 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS122777 | Targeting mitochondrial Complex I in neonatal hypoxia-ischemia | 000 | 3 | NIH | 1/29/2024 | $461,115 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS122855 | Inflammatory changes and glymphatic dysfunction in carbon monoxide neuropathology | 000 | 3 | NIH | 3/8/2024 | $527,983 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R13AI183722 | 14th International Bordetella Symposium | 000 | 1 | NIH | 3/1/2024 | $6,500 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R13HS029601 | ASTARISQ: Addressing systemic and STructurAl Racism to Improve Safety, Quality, and trustworthiness in health delivery systems | 000 | 1 | AHRQ | 2/19/2024 | $50,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K99DA060209 | Postpartum Neurobiological Sequelae of Prescription Opioid Use During Pregnancy | 000 | 1 | NIH | 2/28/2024 | $178,322 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21CA270591 | Dual inhibition of PARP and STAT3 as a novel therapeutic approach for triple-negative breast cancer | 000 | 1 | NIH | 1/18/2024 | $230,361 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD007982 | Racial and Ethnic Minority Acceleration for Health Equity Consortium U01 | 000 | 2 | FDA | 12/29/2023 | $50,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH131566 | Reward, Salience and Value Processing in Youths at Risk for Psychosis: The RSVP Study | 000 | 1 | NIH | 2/16/2024 | $760,952 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03HD114143 | Transcriptional Profiling of the Post-Stroke Immune Response to Tailor Rehabilitation Timelines | 000 | 1 | NIH | 1/31/2024 | $252,000 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA279108 | The pro-metastatic role of androgen receptor in estrogen receptor mutated breast cancer | 000 | 1 | NIH | 1/8/2024 | $656,397 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR083363 | Lipid metabolism in the growth plate | 000 | 1 | NIH | 1/10/2024 | $535,718 |
| 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AG081693 | Deep-Learning Enhanced ASL MRI For Early AD Assessment | 000 | 1 | NIH | 3/12/2024 | $775,807 |
|